Newly prequalified Active Pharmaceutical Ingredient (API)
M
Aabcavir (sulfate) (WHOAPI-377) manufactured by Jiangsu Weiqida Pharmaceutical Co Ltd, has been prequalified by the WHO Prequalific
First delamanid prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Desano’s efavirenz/lamivudine/tenofovir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: